Yuan Jun, Zou Xin-Rong, Han Si-Ping, Cheng Hong, Wang Lan, Wang Jin-Wei, Zhang Lu-Xia, Zhao Ming-Hui, Wang Xiao-Qin
Hubei University of Chinese Medicine, Wuhan, 430065, China.
Renal Division, Department of Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, The Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, 430061, China.
BMC Nephrol. 2017 Jan 14;18(1):23. doi: 10.1186/s12882-017-0441-9.
Although a high incidence of cardiovascular disease (CVD) is observed among chronic kidney disease (CKD) patients in developed countries, limited information is available about CVD prevalence and risk factors in the Chinese CKD population. The Chinese Cohort of Chronic Kidney Disease (C-STRIDE) was established to investigate the prevalence and risk factors of CVD among Chinese CKD patients.
Participants with stage 1-4 CKD (18-74 years of age) were recruited at 39 clinical centers located in 28 cities from 22 provinces of China. At entry, the socio-demographic status, medical history, anthropometric measurements and lifestyle behaviors were documented, and blood and urine samples were collected. Estimated glomerular filtration rate (eGFR) was calculated by the CKD-EPI creatinine equation. CVD diagnosis was based on patient self-report and review of medical records by trained staff. A multivariable logistic regression model was used to estimate the association between risk factors and CVD.
Three thousand four hundred fifty-nine Chinese patients with pre-stage 5 CKD were enrolled, and 3168 finished all required examinations and were included in the study. In total, 40.8% of the cohort was female, with a mean age of 48.21 ± 13.70 years. The prevalence of CVD was 9.8%, and in 69.1% of the CVD cases cerebrovascular disease was observed. Multivariable analysis showed that increasing age, lower eGFR, presence of hypertension, abdominal aorta calcification and diabetes were associated with comorbid CVD among CKD patients. The odds ratios and 95% confidence intervals for these risk factors were 3.78 (2.55-5.59) for age 45-64 years and 6.07 (3.89-9.47) for age ≥65 years compared with age <45 years; 2.07 (1.28-3.34) for CKD stage 3a, 1.66 (1.00-2.62) for stage 3b, and 2.74 (1.72-4.36) for stage 4 compared with stages 1 and 2; 2.57 (1.50-4.41) for hypertension, 1.82 (1.23-2.70) for abdominal aorta calcification, and 1.70 (1.30-2.23) for diabetes, respectively.
We reported the CVD prevalence among a CKD patient cohort and found age, hypertension, diabetes, abdominal aorta calcification and lower eGFR were independently associated with higher CVD prevalence. Prospective follow-up and longitudinal evaluations of CVD risk among CKD patients are warranted.
尽管在发达国家慢性肾脏病(CKD)患者中心血管疾病(CVD)的发病率较高,但关于中国CKD人群中CVD患病率及危险因素的信息有限。中国慢性肾脏病队列研究(C-STRIDE)旨在调查中国CKD患者中CVD的患病率及危险因素。
招募年龄在18 - 74岁的1 - 4期CKD患者,来自中国22个省份28个城市的39个临床中心。入组时,记录社会人口学状况、病史、人体测量指标和生活方式行为,并采集血样和尿样。采用CKD-EPI肌酐方程计算估算肾小球滤过率(eGFR)。CVD诊断基于患者自我报告及经过培训的工作人员对病历的审查。采用多变量逻辑回归模型评估危险因素与CVD之间的关联。
共纳入3459例中国CKD 5期前患者,3168例完成所有必要检查并纳入研究。队列中女性占40.8%,平均年龄为48.21±13.70岁。CVD患病率为9.8%,69.1%的CVD病例为脑血管疾病。多变量分析显示,年龄增加、eGFR降低、高血压、腹主动脉钙化和糖尿病与CKD患者合并CVD相关。与年龄<45岁相比,45 - 64岁人群这些危险因素的比值比及95%置信区间为3.78(2.55 - 5.59),≥65岁人群为6.07(3.89 - 9.47);与1、2期相比,3a期CKD的比值比为2.07(1.28 - 3.34),3b期为1.66(1.00 - 2.62),4期为2.74(1.72 - 4.36);高血压的比值比为2.57(1.50 - 4.41),腹主动脉钙化的比值比为1.82(1.23 - 2.70),糖尿病的比值比为1.70(1.30 - 2.23)。
我们报告了CKD患者队列中的CVD患病率,发现年龄、高血压、糖尿病、腹主动脉钙化和eGFR降低与较高的CVD患病率独立相关。有必要对CKD患者的CVD风险进行前瞻性随访和纵向评估。